What lies ahead for the biotechnology industry?
That question – and many more – will be discussed next week at MassBio’s Annual Conference in Cambridge, MA.
As new members of the Massachusetts Biotechnology Council, the CCC team is excited to join this year’s event entitled “The State of Possible.”
CCC’s membership in MassBio gives us the opportunity to further participate in the growth of the life science ecosystem. We look forward to sharing our expertise in creating copyright compliance and content workflow solutions for organizations within this network of innovative companies.
About MassBio’s Annual Event
This year’s keynote speaker Jeremy Levin, Chairman & CEO of Ovid Therapeutics, will kick off the program with “The State of the State of Possible: Where Are We in the History of Biotech and What Lies Ahead.” Additional topics throughout the two-day event range from leveraging artificial intelligence for drug discovery, to addressing the nation’s opioid crisis.
Meet the CCC Team
We’ll be exhibiting throughout the conference, and we’re excited to share the ways emerging life sciences organizations are using RightFind to accelerate the research process.
If you’re not attending the conference, follow all the action using hashtag #StateofPossible19 and connect with Mass Bio (@MassBio) and CCC (@copyrightclear) on Twitter for up-to-the-minute dispatches from the conference.